Effect of Butylphthalide on Serum CRP, PARK7, NT-3 and Neurological Function in Patients with Acute Cerebral Infarction

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2021 Oct 15

PMID 34650707

Citations 5

Authors

Guangmin Wang

Dandan Ma

Runli Wang

Affiliations

Soon will be listed here.

Abstract

Objective: The effects of butylphthalide on serum C-reactive protein (CRP), Parkinson disease protein 7 (PARK7), and neurotrophin-3 (NT-3) levels, and neurological function in patients with acute cerebral infarction (ACI) were explored in order to provide a reference for clinical treatment of the disease.

Methods: One hundred and twenty patients with ACI treated in our hospital from September 2016 to June 2018 were selected and randomized into the control group and the study group, with 60 cases in each group. Patients in the control group were treated with conventional therapy, while those in the study group were treated with butylphthalide. Clinical efficacy, serum levels of CRP, PARK7, and NT-3, as well as the scores of National Institutes of Health Stroke Scale (NIHSS), Fugl-Meyer Assessment (FMA), and Barthel Index (BI) before and 2 months after treatment were analyzed and compared between the two groups.

Results: The study group had a significantly higher effective rate (93.33%) than the control group (73.33%; P<0.05). Before treatment, differences in serum CRP, PARK7, NT-3, IL-6, IL-8, and IL-10 levels between the study group and the control group were barely notable (P>0.05). After treatment, the study group observed lower serum levels of CRP, PARK7, IL-6, IL-8, and a higher levels of IL-10, NT-3 in comparison with those of the control group (P<0.05). Before treatment, NIHSS, FMA, and BI scores between the two groups did not show significant differences (P>0.05). After treatment, the study group yielded a remarkably lower NIHSS score and higher FMA and BI scores than the control group (P<0.05).

Conclusion: Butylphthalide is effective in the treatment of ACI. It can effectively facilitate the recovery of neurological and motor functions of patients, enhance their quality of life and improve serum CRP, PARK7, and NT-3 levels, which is worthy of clinical promotion.

Citing Articles

Comparative efficacy of neuroprotective agents for improving neurological function and prognosis in acute ischemic stroke: a network meta-analysis.

Wang Y, Li M, Jiang Y, Ji Q Front Neurosci. 2025; 18():1530987.

PMID: 39834702 PMC: 11743486. DOI: 10.3389/fnins.2024.1530987.

Attenuated DSS-Induced Ulcerative Colitis via NF-κB Signaling Pathway and Regulating Gut Microbiota.

Song X, Wang W, Liu L, Zhao Z, Shen X, Zhou L Molecules. 2024; 29(9).

PMID: 38731645 PMC: 11085930. DOI: 10.3390/molecules29092154.

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors.

Li Y, Hong Z, Li S, Xie S, Wang J, Wang J Dis Markers. 2023; 2023:9969437.

PMID: 37082457 PMC: 10113042. DOI: 10.1155/2023/9969437.

Effects of NBP injection on the inflammatory response, oxidative stress response and vascular endothelial function in patients with ACI: A systematic review and meta-analysis.

Liu X, Ma Y, Wang Y, Zhang Q Medicine (Baltimore). 2023; 102(10):e33226.

PMID: 36897673 PMC: 9997797. DOI: 10.1097/MD.0000000000033226.

Protocol of End-PSCI trial: a multicenter, randomized controlled trial to evaluate the effects of DL-3-n-butylphthalide on delayed-onset post stroke cognitive impairment.

Liu Z, Lu W, Gao L, Guo X, Liu J, Gao F BMC Neurol. 2022; 22(1):435.

PMID: 36384493 PMC: 9667601. DOI: 10.1186/s12883-022-02957-y.

References

Qi F, Hu Y, Kang L, Li P, Gao T, Zhang X . Effects of Butyphthalide Combined with Idebenone on Inflammatory Cytokines and Vascular Endothelial Functions of Patients with Vascular Dementia. J Coll Physicians Surg Pak. 2020; 30(1):23-27. DOI: 10.29271/jcpsp.2020.01.23. View

Zacho J, Tybjaerg-Hansen A, Nordestgaard B . C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease. Scand J Clin Lab Invest. 2009; 69(4):442-6. DOI: 10.1080/00365510903056015. View

Zhang H, Peng J, Zhu G, Xu R . Neuroprotective effects of Bcl-2 overexpression on nerve cells of rats with acute cerebral infarction. Genet Mol Res. 2015; 14(3):7696-703. DOI: 10.4238/2015.July.13.15. View

Hess D, Wechsler L, Clark W, Savitz S, Ford G, Chiu D . Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017; 16(5):360-368. DOI: 10.1016/S1474-4422(17)30046-7. View

Zhang W, Huang Y, Li Y, Tan L, Nao J, Hu H . Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial. Clin Drug Investig. 2016; 36(9):697-704. DOI: 10.1007/s40261-016-0415-x. View

Wang S, Ma F, Huang L, Zhang Y, Peng Y, Xing C . Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke. CNS Neurol Disord Drug Targets. 2018; 17(5):338-347. DOI: 10.2174/1871527317666180612125843. View

Ren L, Zhang W, Fang N, Wang J . The influence of electro-acupuncture on neural plasticity in acute cerebral infarction. Neurol Res. 2008; 30(9):985-9. DOI: 10.1179/174313208X325182. View

Jia L, Zhang Y, Ma R, Song Y . Does butylphthalide affect on hemodynamics in patients with watershed stroke?: A protocol of systematic review and meta-analysis. Medicine (Baltimore). 2020; 99(20):e20151. PMC: 7254054. DOI: 10.1097/MD.0000000000020151. View

Wang M, Feng Y, Yuan Y, Gui L, Wang J, Gao P . Use of l-3-n-Butylphthalide within 24 h after intravenous thrombolysis for acute cerebral infarction. Complement Ther Med. 2020; 52:102442. DOI: 10.1016/j.ctim.2020.102442. View

10.

Kwah L, Diong J . National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014; 60(1):61. DOI: 10.1016/j.jphys.2013.12.012. View

11.

Powers W, Kam C, Ritter V, Fine J . Diagnostic accuracy of acute infarcts in multiple cerebral circulations for cardioembolic stroke: Literature review and meta-analysis. J Stroke Cerebrovasc Dis. 2020; 29(7):104849. PMC: 7589525. DOI: 10.1016/j.jstrokecerebrovasdis.2020.104849. View

12.

Xu Z, Zhou Y, Shao B, Zhang J, Liu C . A Systematic Review of Neuroprotective Efficacy and Safety of DL-3-N-Butylphthalide in Ischemic Stroke. Am J Chin Med. 2019; 47(3):507-525. DOI: 10.1142/S0192415X19500265. View

13.

Ding T, Tang L, Hu B, Yuan J, Li X, Wen J . Effects of Arteriovenous Thrombolysis Combined with Mechanical Thrombectomy on Efficacy and Neurological Function of Acute Cerebral Infarct Patients. Biomed Res Int. 2020; 2020:9743075. PMC: 7568809. DOI: 10.1155/2020/9743075. View

14.

Zhao Q, Li W, Li D, Liu T, Wang J, Gao Y . Clinical treatment efficiency of mechanical thrombectomy combined with rhPro-UK thrombolysis for acute moderate/severe cerebral infarction. Eur Rev Med Pharmacol Sci. 2018; 22(17):5740-5746. DOI: 10.26355/eurrev_201809_15842. View

15.

Wo X, Han J, Wang J, Wang X, Liu X, Wang Z . Sequential butylphthalide therapy combined with dual antiplatelet therapy in the treatment of acute cerebral infarction. Pak J Med Sci. 2020; 36(4):615-620. PMC: 7260910. DOI: 10.12669/pjms.36.4.1831. View

16.

Liang Y, Chen J, Zheng X, Chen Z, Liu Y, Li S . Ultrasound-Mediated Kallidinogenase-Loaded Microbubble Targeted Therapy for Acute Cerebral Infarction. J Stroke Cerebrovasc Dis. 2017; 27(3):686-696. DOI: 10.1016/j.jstrokecerebrovasdis.2017.09.063. View

17.

Zhou P, Wang L, Qu M, Shen H, Zheng H, Deng L . Dl-3-N-butylphthalide promotes angiogenesis and upregulates sonic hedgehog expression after cerebral ischemia in rats. CNS Neurosci Ther. 2019; 25(6):748-758. PMC: 6515698. DOI: 10.1111/cns.13104. View

18.

Chen X, Qiu K, Liu H, He Q, Bai J, Lu W . Application and prospects of butylphthalide for the treatment of neurologic diseases. Chin Med J (Engl). 2019; 132(12):1467-1477. PMC: 6629339. DOI: 10.1097/CM9.0000000000000289. View

19.

Hong T, Kuo S, Hu F, Ko W, Hsu L, Huang S . Do interleukin-10 and superoxide ions predict outcomes of cardiac extracorporeal membrane oxygenation patients?. Antioxid Redox Signal. 2013; 20(1):60-8. DOI: 10.1089/ars.2013.5427. View

20.

Huang Y, Xia Z, Wei W, Gao G, Gong J, Li Y . The impact of leucoaraiosis on neurological function recovery in elderly patients with acute cerebral infarction: Clinical study involving 279 Chinese patients. J Int Med Res. 2014; 42(3):857-62. DOI: 10.1177/0300060513507386. View